General Information of Drug Therapeutic Target (DTT) (ID: TT7OGZP)

DTT Name Casein kinase 1 (CK1)
Gene Name CK1
DTT Type
Preclinical target
[1]
UniProt ID
KC1A_HUMAN ; KC1D_HUMAN ; KC1E_HUMAN ; KC1G1_HUMAN ; KC1G2_HUMAN ; KC1G3_HUMAN
TTD ID
T72915
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
KEGG Pathway
Wnt signaling pathway (hsa04310 )
Hedgehog signaling pathway (hsa04340 )
Alzheimer disease (hsa05010 )
Pathways of neurodegeneration - multiple diseases (hsa05022 )
Human papillomavirus infection (hsa05165 )
Breast cancer (hsa05224 )
Hepatocellular carcinoma (hsa05225 )
Gastric cancer (hsa05226 )
Reactome Pathway
Beta-catenin phosphorylation cascade (R-HSA-196299 )
Disassembly of the destruction complex and recruitment of AXIN to the membrane (R-HSA-4641262 )
Signaling by GSK3beta mutants (R-HSA-5339716 )
CTNNB1 S33 mutants aren't phosphorylated (R-HSA-5358747 )
CTNNB1 S37 mutants aren't phosphorylated (R-HSA-5358749 )
CTNNB1 S45 mutants aren't phosphorylated (R-HSA-5358751 )
CTNNB1 T41 mutants aren't phosphorylated (R-HSA-5358752 )
APC truncation mutants have impaired AXIN binding (R-HSA-5467337 )
AXIN missense mutants destabilize the destruction complex (R-HSA-5467340 )
Truncations of AMER1 destabilize the destruction complex (R-HSA-5467348 )
Degradation of GLI2 by the proteasome (R-HSA-5610783 )
GLI3 is processed to GLI3R by the proteasome (R-HSA-5610785 )
Activation of SMO (R-HSA-5635838 )
Maturation of nucleoprotein (R-HSA-9694631 )
Degradation of beta-catenin by the destruction complex (R-HSA-195253 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
2 Preclinical Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
CKI-7 DMV0RFU Mood disorder 6A60-6E23 Preclinical [1]
LH846 DMJXZIS Mood disorder 6A60-6E23 Preclinical [2]
------------------------------------------------------------------------------------

References

1 Crystal structures of two aminoglycoside kinases bound with a eukaryotic protein kinase inhibitor. PLoS One. 2011 May 9;6(5):e19589.
2 A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10608-11.